DAVID LASKOW-POOLEY JOINS BOARD OF TESTAVEC LTD David Laskow- Pooley has joined the company to accelerate the commercialisation of the...

TestAVec researchers, lead by CSO Professor Michael Themis, have devised new protocols for making high titre HIV-1 lentivirus particles...

From all of us here at TestAVec, we wish you a happy holiday season and new year. Time to enjoy the festive period and go into 2024 to...

TestAVec and Vidiia are working together to accelerate DiNARep to commercial testing. DiNARep identifies if patients are able to repair...

Recently, the US Food and Drug Administration (FDA) has expressed that it is investigating cases of blood cancer in CAR-T therapies....